Using mobile technology to manage cardiovascular risks in stroke patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CARDIOSTROKE trial is a randomized study that compares mobile-device-assisted management of hypertension and screening for hidden atrial fibrillation against standard care in patients who have recently experienced an ischemic stroke or transient ischemic attack. The trial aims to enroll 405 participants, who will be divided into two groups: one receiving standard care and the other undergoing three weeks of ECG monitoring and self-monitoring of blood pressure with the help of mobile technology. The primary outcomes include the detection of new-onset atrial fibrillation and changes in mean blood pressure after 12 months. This innovative approach seeks to improve the management of cardiovascular risk factors in stroke patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
* Age ≥40 years
* Pre-existing or newly diagnosed hypertension
* Informed consent from the patient or legal representative

Exclusion Criteria:

* Known high-risk source of cardioembolism
* Known indication for anticoagulation
* Contraindication for anticoagulation
* Pacemaker
* Non-compliance to study interventions as judged by the investigator
* Serious condition hampering the study conduct

Where it's running

• Kanta-Häme Central Hospital
  Hämeenlinna, Finland Recruiting
• Helsinki University Hospital
  Helsinki, Finland Recruiting
• Hyvinkää Hospital
  Hyvinkää, Finland Recruiting
• Päijät-Häme Central Hospital
  Lahti, Finland Recruiting

Study contacts

• Study coordinator: Tuomas Lumikari, MD
• Email: tuomas.lumikari@helsinki.fi
• Phone: +35894711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Non-contrast MRA vs Carotid Doppler for detecting carotid artery narrowing in stroke or TIA

  This study tests whether non-contrast MRA can match or improve upon carotid Doppler in finding and grading carotid artery narrowing in adults with ischemic stroke or TIA.

  Recruiting Sohag University · Sohag, Sohag Governorate · NCT07756775

• Rural Telemedicine-Enabled Care to Prevent Stroke in Older Adults in China

  A telemedicine-supported care model led by rural doctors will be tested to see if it can reduce stroke and heart problems in adults 65+ living in rural China.

  Recruiting at 2 sites Jiangsu Province (Suqian) Hospital · Suqian, Jiangsu and 1 other locations · NCT07628283

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Long-term follow-up after a year of regular exercise for people with symptomatic intracranial arterial stenosis

  This follow-up will see if benefits from a year of regular physical exercise last over three years for people with symptomatic intracranial arterial stenosis who completed the RESIST program.

  Recruiting Capital Medical University · Beijing · NCT07242768

• When to start direct oral anticoagulants after clot removal for stroke with atrial fibrillation

  This will test whether starting direct oral anticoagulants early versus waiting after emergency clot removal is safer and better at preventing new strokes for people with atrial fibrillation who show bleeding changes on imaging.

  Recruiting at 37 sites Capital Medical University · Ma’anshan, Anhui and 36 other locations · NCT07139314

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.